全文获取类型
收费全文 | 2385篇 |
免费 | 211篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 106篇 |
妇产科学 | 26篇 |
基础医学 | 289篇 |
口腔科学 | 21篇 |
临床医学 | 215篇 |
内科学 | 573篇 |
皮肤病学 | 49篇 |
神经病学 | 101篇 |
特种医学 | 39篇 |
外科学 | 358篇 |
综合类 | 85篇 |
一般理论 | 2篇 |
预防医学 | 206篇 |
眼科学 | 136篇 |
药学 | 182篇 |
中国医学 | 4篇 |
肿瘤学 | 151篇 |
出版年
2023年 | 13篇 |
2022年 | 35篇 |
2021年 | 82篇 |
2020年 | 40篇 |
2019年 | 53篇 |
2018年 | 62篇 |
2017年 | 54篇 |
2016年 | 61篇 |
2015年 | 73篇 |
2014年 | 83篇 |
2013年 | 92篇 |
2012年 | 162篇 |
2011年 | 148篇 |
2010年 | 97篇 |
2009年 | 95篇 |
2008年 | 123篇 |
2007年 | 135篇 |
2006年 | 148篇 |
2005年 | 115篇 |
2004年 | 93篇 |
2003年 | 96篇 |
2002年 | 93篇 |
2001年 | 58篇 |
2000年 | 33篇 |
1999年 | 56篇 |
1998年 | 27篇 |
1997年 | 16篇 |
1996年 | 24篇 |
1995年 | 20篇 |
1994年 | 12篇 |
1993年 | 10篇 |
1992年 | 29篇 |
1991年 | 24篇 |
1990年 | 43篇 |
1989年 | 36篇 |
1988年 | 25篇 |
1987年 | 26篇 |
1986年 | 26篇 |
1985年 | 18篇 |
1984年 | 7篇 |
1983年 | 12篇 |
1982年 | 7篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1973年 | 11篇 |
1972年 | 8篇 |
1966年 | 7篇 |
1961年 | 8篇 |
排序方式: 共有2599条查询结果,搜索用时 15 毫秒
31.
GnRH agonists have been found to be clinically useful in several hormone-sensitive conditions, including cancer. However, there is controversy regarding a direct action of these agents on the pathologic tissue of a given disease process, in particular, tumors. In this study, we examined the effects of D-Trp(6) -LHRH, a potent GnRH agonist, on the expression of an increasingly important angiogenesis factor, VPF (vascular permeability factor)/VEGF (vascular endothelial growth factor). Ovarian carcinoma cell lines exposed to D-Trp(6) -LHRH in culture demonstrated a reversible inhibition of VPF mRNA expression and a parallel decrease in the endothelium-specific mitogenic activity of the conditioned media from these treated cultures. This study reports a novel activity of a GnRH agonist and provides a starting point to investigate the in vivo anti-angiogenic properties of GnRH peptide analogs. 相似文献
32.
33.
34.
Chakrabarti R Vikramadithyan RK Dileepkumar T Kumar KB Kumar MP Misra P Rao PB Lohray VB Lohray BB Rajagopalan R 《Arzneimittel-Forschung》1999,49(11):905-911
Euglycemic and hypolipidemic activities of a novel indole analogue of thiazolidinedione, DRF 2189 (CAS 172647-53-9), have been evaluated in different animal models. Compared to troglitazone (CAS 97322-87-7), DRF 2189 exhibited interesting plasma glucose and triglyceride lowering activity in genetically diabetic and obese db/db mice. It also produced a significant reduction in plasma glucose, triglyceride, total cholesterol levels and improvement in oral glucose tolerance in another genetic mouse model, the ob/ob mice. In high-fat diet fed Sprague-Dawley rats, DRF 2189 treatment showed improvement in plasma lipid parameters. Like other thiazolidinediones, this compound also possesses peroxisome proliferator activated receptor gamma (PPAR gamma) transactivation potential. In anaesthetized rat experiment, DRF 2189 produced a transient fall in blood pressure without any change in the ECG pattern. It showed non-specific smooth muscle relaxant activity against acetylcholine, histamine and potassium chloride induced contractions in isolated guinea pig ileum. A twenty-eight-day toxicity study in Wistar rats did not show any signs of treatment related adverse effects. The overall antidiabetic and hypolipidemic activities of DRF 2189 are comparable with rosiglitazone (CAS 155141-29-0) and superior to troglitazone. In conclusion, results from these preclinical studies indicate that DRF 2189, a novel thiazolidinedione, has a marked potential for the management of type-2 diabetes. 相似文献
35.
K A Reddy B B Lohray V Bhushan A S Reddy N V Rao Mamidi P P Reddy V Saibaba N J Reddy A Suryaprakash P Misra R K Vikramadithyan R Rajagopalan 《Journal of medicinal chemistry》1999,42(17):3265-3278
Several thiazolidinediones having chroman moieties were synthesized and evaluated for their euglycemic and hypolipidemic activities. Some of the analogues having an aminoalkyl group as a linker between the chroman ring and 4-[5-(2,4-dioxo-1, 3-thiazolidinyl)methyl]phenoxy moiety seem to be better than troglitazone. In vitro transactivation assays of PPARgamma have been carried out with these glitazones to understand their molecular mechanism. For the first time we have found that some of the unsaturated thiazolidinediones are superior to their saturated counterpart in the in vivo assay. A more potent thiazolidinedione analogue than troglitazone is reported. Pharmacokinetic studies have shown that protection of the OH group in the chroman moiety leads to a decrease in metabolism, thereby resulting in a superior pharmacological profile. 相似文献
36.
Lorenz M Evering WE Provencher A Blue JT Lewis HB Hazelette JR Rajagopalan P Meunier PC Car BD 《Toxicology and applied pharmacology》1999,155(3):227-236
DMP 406 is an atypical antipsychotic, antischizophrenic drug, biochemically related to clozapine, which exerts its desired pharmacologic effects through selective antagonism of 5-hydroxytryptamine and dopamine-receptor subtypes. Clozapine therapy is clinically associated with severe granulocytopenia in a small subset of patients. In the course of a 3-month toxicity study in dogs, severe neutropenia, thrombocytopenia, marked myeloid and erythroid left-shifted bone marrow hyperplasia with increased erythrophagocytosis, positive Coombs' tests, and hypergammaglobulinemia occurred in individual females dosed with 30 mg/kg/day of DMP 406. Related but less severe changes were also observed in males. Sera or purified immunoglobulins from affected and control dogs were tested in methylcellulose-based, canine hematopoietic colony-forming unit (CFU) assays with or without DMP 406. Neither size nor number of erythroid or myeloid CFUs differed between cultures containing control or affected dog serum components. Sera from individual affected dogs but not controls resulted in moderate numbers of fibroblast-like CFUs, suggesting DMP 406-associated marrow stromal cell-modifying, serum activities to be present. DMP 406 alone resulted in a concentration-dependent reduction of erythroid and myeloid CFUs with an approximate IC50 of 3.0 microg/mL. Taken together, DMP 406-induced granulocytopenia and bone marrow dyscrasia appear likely to result from both immune-mediated and direct drug-induced myelotoxicity. 相似文献
37.
Kumar Rajagopalan David Peereboom G. Thomas Budd Thomas Olencki Siva Murthy Paul Elson Denise McLain Ronald Bukowski 《Investigational new drugs》1999,16(3):255-258
Circadian administration of chemotherapy has been reported to decrease toxicity and possibly enhance efficacy. Between March 1991 and December 1993, 18 evaluable patients with progressive, hormone-refractory metastatic prostate cancer were treated in this phase II trial of circadian infusion floxuridine (FUDR). The drug was delivered through a central venous catheter using a CADD-Plus computerized pump such that approximately 70% of the drug was administered between 3 and 9 p.m. and the rest (30%) was administered between 9 p.m. and 3 p.m. The dose of FUDR was 0.15 mg/kg/day × 14 days every 4 weeks. A total of 79 complete cycles was administered.Two of 18 evaluable patients (11.1%) had decreases in PSA lasting five and eight months. No objective responses or improvement in bone scans was noted. The major toxicity observed was diarrhea. Although circadian infusion FUDR is feasible and tolerable, it has limited activity in hormone refractory prostate cancer. 相似文献
38.
Vascular endothelial growth factor (VEGF)/ vascular permeability factor (VPF) is emerging as an important growth factor in a variety of tumor types. As a potent endothelial cell mitogen and vascular permeabilizing agent, VEGF/VPF has the unique functional capacity to mediate the component events of solid tumor neovascularization and ascites tumor growth. In the present series of investigations, our experimental hypothesis was that VEGF/VPF is a critical mediator of ovarian carcinoma-associated ascites formation and solid tumor growth. Athymic nude mice xenotransplanted with human ovarian carcinoma cell lines received either a preimmune rabbit serum or VEGF/VPF antiserum. Compared with the control group receiving the preimmune serum, the antiserum-treated animals displayed a 10- and 12-fold reduction in ascites accumulation and solid tumor growth, respectively. The administration of a neutralizing antiserum to VEGF/VPF conferred a modest survival advantage to animals harboring intraperitoneal tumors. These data demonstrate the significance of VEGF/VPF in the pathogenesis of ovarian carcinoma and suggest that interventions targeting this growth factor and/or its receptor may be of therapeutic value in the management of ovarian cancer. 相似文献
39.
Depleted uranium is now widely used in the armor of military vehicles as well as in kinetic-energy penetrators designed to defeat enemy armor. As a result, the potential that personnel will be wounded by depleted uranium fragments has increased. Because toxicities associated with depleted uranium fragments may ultimately require different treatment protocols than those used for traditional metal fragment injuries, a method to rapidly detect the presence of depleted uranium in surgically excised shrapnel fragments is required. By treating the shrapnel fragment with an extracting agent, such as nitric acid, for 5 minutes in an ultrasonic cleaner, sufficient metal is solubilized to allow for colorimetric detection using a pyridylazo dye. Although several metals are capable of being detected under these conditions, the reaction can be made specific for depleted uranium through the use of masking agents such as sodium citrate and ethylenediaminetetraacetic acid. This procedure allows for the rapid (< 15 minutes) extraction and detection of depleted uranium in metal shrapnel fragments. 相似文献
40.
Michael Friedman MD Hani Ibrahim MD Vidyasagar Ramakrishnan MBBS MS 《Operative Techniques in Otolaryngology》2003,14(2):90-93
The large thyroid mass with substernal extension often requires a combination of cervical and thoracic approach for its access and removal. We have developed a technique that uses a cervical incision and combines clear access to the mass with low morbidity. The principle features include complete sternocleidomastoid mobilization, early identification of the neurovascular pedicle through a lateral approach, and finger dissection to deliver the substernal component of the mass. This article also describes the elements of our technique in detail, from preoperative considerations through wound closure and discusses the debate concerning the ideal treatment of these challenging tumors. 相似文献